Meet the AI founders using agents to build instantly profitable 3-person companies

Nine months ago, Sam Brown was out of a job. The reason, he’ll tell you without a sense of bitterness, was artificial intelligence. The company he’d spent years building a career inside decided it needed fewer people, and he was one of them.

Recommended Video

“I got laid off nine months ago, and it was AI-related,” said Brown, 48, with a career that stretches back to 2000, aside from a few months as a ball boy for the Denver Nuggets in his youth. “I had to sit there and say, ‘This is a blessing, because I get a head start on everyone else that’s going to have to go through this in a little while.'”

He didn’t spend long feeling sorry for himself. Instead, Brown joined a three-person startup with no venture funding, no engineering team, and no traditional software infrastructure. What they did have were 12 AI agents.

$300 in, $300,000 out

Fathom AI, an Austin-based sales enablement platform built specifically for the medical aesthetics industry, launched in early 2026. Within 12 weeks, it achieved an estimated annual recurring revenue of $300,000, gross margins north of 90%, and operating costs under 10% of revenue, according to records reviewed by Fortune. And the total capital invested to start the company was just $300.

“We launched 2.5 months ago, and right now, we have $300,000 in ARR,” said Brown, who manages the three-person company’s finances as the president of Fathom AI.

The company has taken no outside funding. When venture capitalists came calling, Fathom got all the way to the finish line on a term sheet and walked away—not because the deal was bad, but because they genuinely couldn’t figure out what they’d spend the money on.

“The VC said, ‘You’re going to need an engineering team of this size, a customer success team of this size,'” Brown recalled, adding that when he and Fathom’s founder and CEO Ben Hooten walked out of the meeting, they basically said, “We’re not going to need that.”

courtesy of Fathom AI

By year-end, Fathom projects $5 million in ARR across 15 to 18 enterprise customers. The team is structured as a partnership specifically to distribute profits now, a deliberate decision to get paid rather than hold out for a distant exit in a market none of them can predict.

Brown explained to Fortune that the partnership is essentially like collecting a paycheck. “We’d rather take the money now and then, there’s not a lot to reinvest in, because we don’t have huge costs.”

“Hell,” added Dan Crump, the senior member of the trio, at 56 years old, “we got paid today, as a matter of fact. We’re cash-flow positive.”

The skeptic who became the proof

Kirk Gunhus has been in the medical aesthetics industry for 30 years. He has gray hair and, by his own cheerful admission, is “not a technology guy.” He wasn’t interested when Fathom AI first pitched him on switching vendors.

The origin story starts with a frustrated rant. The CEO, Hooten, then still a sales rep, was sitting in one of Gunhus’ meetings when Gunhus, a couple of beers in, unloaded on the state of sales technology. “You’ve got all this stuff here, and none of it really works well,” Gunhus said. “Someone needs to just put it all together, so when I walk into a zip code, I know exactly what accounts are perfect for us to go after.”

He forgot about his rant immediately, but Hooten didn’t. Gunhus said he got a call the very next weekend from Hooten, who said he put a plan together.

Gunhus agreed to a pilot with six sales reps. The company, he said, couldn’t afford the subscription, but every one of those six reps paid individually to work with Fathom AI. That’s “because it works,” Gunhus said. “It’s making them so much money.”

The results bore him out. In all of 2024, one of Gunhus’ consulting clients, Tiger Aesthetics, did not open a single net new account. Within one quarter of deploying Fathom, he said they had opened 225. “The bosses over at Tiger are like, ‘[Give them] whatever they want.’ They just saved a ton of money.”

The medical aesthetics industry is a multibillion-dollar world of plastic surgeons, dermatologists, med spas, and device manufacturers and, according to Fathom AI and their clientele, it’s ripe for disruption. Sales have historically been entirely manual. Reps cold-called, drove routes blind, and relied on memory and intuition to figure out who to see and when.

Fathom replaces all of that. A rep enters a zip code, and the platform surfaces every nearby account that fits their product profile, ranked by fit. It layers in real-time Google search data so a rep can walk into a doctor’s office and say, with specificity, what that physician’s patients are searching for. It also serves as a live training tool: new hires roleplay sales scenarios against an AI that corrects their technique in real time, flagging wrong answers and asking follow-up questions.

The team that isn’t supposed to exist

Hooten, the CEO and the junior member of the group at 39, explained to Fortune that his 12 agent co-work